Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated greater occipital nerve methylprednisolone injections for chronic cluster headache prophylaxis
2021-006687-25Phase 3Active
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cluster Headache (CH) comparing Active methylprednisolone GON injection with Placebo GON injection (2 arms). Primary endpoint: Retention rate. Started Apr 2022; status: active.
02
Drugs
methylprednisolone
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on 2021-006687-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006687-25.